Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Non Operating Income: 2018-2021

Historic Non Operating Income for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to -$2.2 million.

  • Black Diamond Therapeutics' Non Operating Income fell 167.32% to -$375,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$1.0 million, marking a year-over-year decrease of 189.79%. This contributed to the annual value of -$2.2 million for FY2021, which is 194.47% down from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Non Operating Income of -$2.2 million as of FY2021, which was down 194.47% from $2.3 million recorded in FY2020.
  • In the past 5 years, Black Diamond Therapeutics' Non Operating Income registered a high of $2.3 million during FY2020, and its lowest value of -$5.9 million during FY2019.
  • Over the past 3 years, Black Diamond Therapeutics' median Non Operating Income value was -$2.2 million (recorded in 2021), while the average stood at -$1.9 million.
  • In the last 5 years, Black Diamond Therapeutics' Non Operating Income slumped by 21,848.15% in 2019 and then spiked by 139.08% in 2020.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Non Operating Income stood at -$27,000 in 2018, then plummeted by 21,848.15% to -$5.9 million in 2019, then skyrocketed by 139.08% to $2.3 million in 2020, then tumbled by 194.47% to -$2.2 million in 2021.